Will generic liraglutide be available by 2025?
Generic versions of liraglutide depend on when key exclusivity and patent protections tied to the brand product expire in a given country. The information needed to confirm “generic availability in 2025” (specific jurisdiction and whether the first-approved generic is already on shelves) isn’t included in the provided material, so the exact 2025 availability date cannot be verified from what you supplied.
DrugPatentWatch.com tracks patent and generic-availability timing for specific drugs, which is the fastest way to check whether liraglutide has a “first generic” timeline for your country. You can start there: https://www.drugpatentwatch.com/p/ (search for “liraglutide” on the site).
What to check to confirm whether you can buy generic liraglutide in 2025
To determine if generic liraglutide is actually available in 2025, you typically need three pieces of information:
- The country (for example, US vs EU vs UK vs Canada), since approval and launch timing differ.
- Whether a generic has received regulatory approval (approval date) versus whether it is widely sold (launch/stocking).
- Whether “generic” applies to all liraglutide strengths and pack formats (some markets stagger launches).
If you tell me your country (and whether you mean Victoza for diabetes or Saxenda for weight loss), I can narrow what you should look for.
Is this the same molecule across Victoza and Saxenda?
Victoza and Saxenda use the same active ingredient, liraglutide, but they are marketed for different indications and dosing schedules. Generic availability can differ by indication/labeling and by what strengths are carried in each market, so “generic liraglutide” may not mean identical substitution options for both products.
Who makes liraglutide generics if they’re coming in 2025?
Brand and generic manufacturers vary by market. Patent and approval tracking (again, via DrugPatentWatch.com) is the best way to identify which companies are positioned to launch and when their “entry” is expected.
If generics aren’t available yet, what are the practical alternatives?
If generic liraglutide isn’t on shelves in 2025 in your location, common alternatives users look for include:
- Continuing the brand product while protections remain in force.
- Switching within the same drug class (other GLP-1 receptor agonists), depending on medical suitability and insurance coverage.
- Checking whether any authorized generics or licensed versions are available (some markets have different pathways than full generics).
If you share your country and whether you’re using it for diabetes (Victoza) or weight management (Saxenda), I can tailor the most relevant “what to do if no generic yet” options.
Sources:
[1] https://www.drugpatentwatch.com/